Moderna Inc. buy UBS Group AG
Start price
24.10.24
/
50%
€48.59
Target price
24.10.25
€99.80
Performance (%)
-44.20%
Price
12:43
€27.11
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Moderna Inc. is performing very badly with a performance of -44.20%. This prediction currently runs until 24.10.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | -1.910% | -1.910% |
| iShares Core DAX® | -0.727% | 2.783% |
| iShares Nasdaq 100 | 1.839% | 5.294% |
| iShares Nikkei 225® | -2.033% | -0.196% |
| iShares S&P 500 | 1.334% | 4.044% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $140.00 to $108.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat